PAHC FY 2017 Earnings Report — Phibro Animal Health Corporation Revenue & Financial Results | Market Cap Arena

Phibro Animal Health CorporationPAHC

FY 2017 Earnings

Reported August 30, 2017

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2017	Prior Q	FY 2016	QoQ Change	YoY Change
Revenue	$764M	—	$752M	—	1.7%
Op. Income	$98M	—	$86M	—	14.2%
Gross Margin	32.5%	—	31.8%	—	0.7pp
Net Margin	8.5%	—	11.0%	—	-2.6pp
EPS (Diluted)	$1.61	—	$2.07	—	-22.2%
Free Cash Flow	$78M	—	$866.0K	—	8849.2%

Revenue Flow

Item	Amount
REVENUE	$764M
Cost of Revenue	$516M
GROSS PROFIT	$248M
R&D Expenses	$9M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$150M
Other Expenses	$0
Operating Expenses	$150M
Cost & Expenses	$666M
OPERATING INCOME	$98M
Interest Income	$2M
Interest Expense	$17M
Other Income/Expenses	-$17M
INCOME BEFORE TAX	$81M
Income Tax Expense	$16M
Net Income from Continuing Ops	$65M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$65M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$65M
D&A	$26M
EBIT	$97M
EBITDA	$123M
EPS	$2
EPS Diluted	$2

Income Statement

Item	Amount
REVENUE	$764M
Cost of Revenue	$516M
GROSS PROFIT	$248M
R&D Expenses	$9M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$150M
Other Expenses	$0
Operating Expenses	$150M
Cost & Expenses	$666M
OPERATING INCOME	$98M
Interest Income	$2M
Interest Expense	$17M
Other Income/Expenses	-$17M
INCOME BEFORE TAX	$81M
Income Tax Expense	$16M
Net Income from Continuing Ops	$65M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$65M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$65M
D&A	$26M
EBIT	$97M
EBITDA	$123M
EPS	$2
EPS Diluted	$2

Cash Flow Statement

Item	Amount
Net Income	$65M
Depreciation & Amortization	$26M
Stock-Based Compensation	$0
Deferred Income Tax	-$28.0K
Other Non-Cash Items	$128M
Change in Working Capital	$1M
OPERATING CASH FLOW	$98M
Capital Expenditure	-$21M
Acquisitions (Net)	$0
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	-$1M
NET CASH FROM INVESTING	-$22M
Net Debt Issuance	-$40M
Common Stock Repurchased	$0
Common Dividends Paid	-$16M
Other Financing Activities	-$4M
NET CASH FROM FINANCING	-$54M
FREE CASH FLOW	$78M
Net Change in Cash	$22M

Balance Sheet

Item	Amount
Cash & Equivalents	$56M
Short-Term Investments	$0
Net Receivables	$126M
Inventory	$161M
Other Current Assets	$21M
TOTAL CURRENT ASSETS	$364M
PP&E (Net)	$127M
Goodwill	$24M
Intangible Assets	$55M
Long-Term Investments	$9M
Tax Assets	$23M
Other Non-Current Assets	$21M
TOTAL NON-CURRENT ASSETS	$260M
TOTAL ASSETS	$623M
Account Payables	$57M
Short-Term Debt	$6M
Deferred Revenue	$0
Other Current Liabilities	$38M
TOTAL CURRENT LIABILITIES	$116M
Long-Term Debt	$307M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$9M
Other Non-Current Liabilities	$41M
TOTAL NON-CURRENT LIABILITIES	$356M
TOTAL LIABILITIES	$472M
Common Stock	$4.0K
Additional Paid-In Capital	$124M
Retained Earnings	$83M
Treasury Stock	$0
Accum. Other Comp. Income	-$55M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$151M
Minority Interest	$0
TOTAL EQUITY	$151M
TOTAL LIABILITIES & EQUITY	$623M
Total Debt	$313M
Net Debt	$257M